Agios Pharmaceuticals (AGIO) Change in Taxes (2012 - 2025)

Agios Pharmaceuticals (AGIO) posted Change in Taxes of -$683000.0 for Q2 2025, down 263.3% on a QoQ basis from -$188000.0 in Q1 2025.

Agios Pharmaceuticals (AGIO) Change in Taxes (2012 - 2025) Analysis & Trends

Agios Pharmaceuticals' Change in Taxes history runs 6 years deep, the most recent figure standing at -$683000.0 for Q2 2025.

Quarterly Change in Taxes changed N/A year-over-year to -$683000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$683000.0 (down 200.0% YoY) and the FY2025 annual result came in at -$871000.0, down 200.0% from the prior year.
Change in Taxes was -$683000.0 for Q2 2025 at Agios Pharmaceuticals, down from -$188000.0 in the prior quarter.
Across five years, Change in Taxes topped out at $52.7 million in Q3 2024 and bottomed at -$51.8 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-8,939.03
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Agios Pharmaceuticals	2.13 Bn	2.13 Bn	19.43 Mn	-

Download Data